
Research Article
A Web-Based Vaccine Distribution System for Covid-19 Using Vaxallot
@INPROCEEDINGS{10.1007/978-3-031-48891-7_31, author={B. Valarmathi and N. Srinivasa Gupta and G. Prakash and A. BarathyKolappan and N. Padmavathy}, title={A Web-Based Vaccine Distribution System for Covid-19 Using Vaxallot}, proceedings={Cognitive Computing and Cyber Physical Systems. 4th EAI International Conference, IC4S 2023, Bhimavaram, Andhra Pradesh, India, August 4-6, 2023, Proceedings, Part II}, proceedings_a={IC4S PART 2}, year={2024}, month={1}, keywords={Vaccine Distribution Coronavirus Pandemic Priority Index Excess Handling}, doi={10.1007/978-3-031-48891-7_31} }
- B. Valarmathi
N. Srinivasa Gupta
G. Prakash
A. BarathyKolappan
N. Padmavathy
Year: 2024
A Web-Based Vaccine Distribution System for Covid-19 Using Vaxallot
IC4S PART 2
Springer
DOI: 10.1007/978-3-031-48891-7_31
Abstract
Vaxallot seeks to implement a system to distribute vaccines across high-risk groups accounting for various parameters and prove to be superior to what conventional systems are capable of today. It is a Python flask-based tool backed by infrastructure and data resources from the Covid India central repository; all it needs is a single channel input and a single parameter of the value produced, and the algorithm will take care of the rest. Since it’s Python-based and has an active integration with google sheets, live value updating could be possible for the real-time output of the distribution. The novelty of the proposed mechanism is the unique priority index, a score that accounts for an array of factors associated with the pandemic and is computed for regions in question here; this makes way for better distribution of vaccines. The application has an exclusive segment centered on handling excess units, if any. Moreover, since the application is developed to suit the needs of dynamic demographics, any region can roll out this application for purposes they desire to serve the masses. Since it isn’t bound by a coronavirus, it can be used by the healthcare industry as they deem fit.